Dulac Edward J Iii

EDGAR CIK 0001821530

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
CFO
EVP, Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
3
($234,185)
-19,167 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
07/22/2026
07/24/2026
Sell
-8,111 @ $11.25
 ($91,249) 148,175 (-5.19%) Direct
07/02/2026
10b5-1
07/06/2026
Sell
-4,677 @ $18.00
 ($84,186) 156,286 (-2.91%) Direct
01/05/2026
01/07/2026
Sell
-6,379 @ $9.21
 ($58,751) 99,683 (-6.01%) Direct